Bond.az White LogoBond.az Black Logo

NervGen stock slumps on dilutive offering

NervGen Pharma shares plummet 39.7% after dilutive share offering. Expected proceeds of $60 million.

Matthew King
ByMatthew King- Senior Editor
|
0

Bond.az - NervGen Pharma Corp (NASDAQ:NGEN) shares dropped 39.7% in premarket Friday after announcing a dilutive public offering.

The clinical-stage biopharmaceutical company priced an offering of 24 million common shares at $2.50 each, plus warrants for another 24 million shares at $3.68, exercisable for five years.

Expected gross proceeds are around $60 million. The deal is set to close May 26, 2026.

Funds will be used to advance the NVG-291 candidate through clinical studies and for corporate purposes.

More News
Today / 13:33
|
510

Why Wingtech stock is falling today

Wingtech Technology stock falls 3.6% due to dispute with Nexperia and delisting risk. Revenue drops 94% in Q1.

0
Today / 13:20
|
345

Novo Nordisk Targets 2/3 Cut in Drug Launch Times with AI

Novo Nordisk aims to cut drug launch times by two-thirds using AI. Its Bengaluru center plays a key role in global launches.

0
Today / 13:11
|
654

Nokia wins from AI and cloud capex cycle

Morgan Stanley raised Nokia target to €14, citing AI and cloud spending boom. Nokia is top pick with 100% stock surge.

0
Today / 13:01
|
310

Conduent stock jumps 15% on $164M sale

Conduent shares jump 15% after the company agrees to sell its public transit unit for $164 million. The deal is expected to close by 2026.

0
Today / 12:53
|
630

Denali stock drops after Parkinson drug fails trial

Denali Therapeutics stock falls after Parkinson's drug BIIB122 fails Phase 2b trial. Shares drop 2.9% premarket.

0
Today / 12:44
|
412

European steel output falls 2.6%

European steel output fell 2.6% in April. Global production declined 2%. Read more on Bond.az.

0
Today / 12:02
|
750

Dick's on JPM Positive Catalyst Watch

JPMorgan placed Dick's Sporting Goods on Positive Catalyst Watch before Q1 earnings, raising sales and profit estimates above consensus.

0
Today / 11:43
|
362

US equity funds see outflows on yield caution

US equity funds post second weekly outflow amid yield caution and inflation worries. Tech sector still sees inflows while industrials and financials lag.

0
Today / 11:42
|
816

US Housing Softness: DA Davidson Highlights Trex, LPX

DA Davidson highlights Trex and LPX amid continued softness in US housing market. April data shows mixed trends, but repair and remodeling exposure supports these stocks.

0
Today / 10:23
|
249

Space ETFs Surge Ahead of SpaceX IPO

Space ETFs see record inflows ahead of SpaceX IPO. New funds launch rapidly, but analysts warn of portfolio overlap and sector risks.

0
Today / 10:13
|
254

Chalco approves $1B alumina project in Guinea

Chalco board approves $1 billion alumina project in Guinea, its first overseas refinery with 1.2 million tons annual capacity.

0
Today / 10:04
|
583

Why is Julius Baer stock plunging today?

Julius Baer stock plunges 8.3% despite strong profits as weak client inflows disappoint investors. Read more on Bond.az.

0
...
NervGen stock slumps on dilutive offering | Bond.az